Study guide
5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections
APMLE Part I Basic Sciences Podiatry
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Lower Extremity Osteology
1.1 APMLE Part I Exam Structure, Policies & Scoring 1.2 Foot Osteology: Tarsals, Metatarsals, Phalanges & Sesamoids 1.3 Leg & Ankle Osteology: Tibia, Fibula & The Ankle Mortise 1.4 Pelvis, Femur & Patella Osteology: Landmarks & Biomechanics
2 Chapter 2: Lower Extremity Arthrology & Ligaments
2.1 Foot Articulations: Subtalar, Midtarsal, Lisfranc & Digital Joints 2.2 Talocrural (Ankle) & Knee Joints: Ligaments & Kinematics 2.3 Hip Joint & Pelvic Articulations: Capsular Structures & Dynamics
3 Chapter 3: Lower Extremity Myology & Compartments
3.1 Anterior & Lateral Compartments of the Leg 3.2 Superficial & Deep Posterior Compartments of the Leg 3.3 Plantar Layers & Intrinsic Musculature of the Foot 3.4 Thigh & Gluteal Musculature: Attachments & Innervations
4 Chapter 4: Lower Extremity Neurovascular & Topographical Anatomy
4.1 Lumbar & Sacral Plexuses, Peripheral Nerves & Dermatomes 4.2 Arterial Network, Venous Drainage & Lymphatics 4.3 Tarsal Tunnel, Femoral Triangle & Topographical Spaces
5 Chapter 5: Microbiology: Bacteriology, Zoonoses & Laboratory Methods
5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections 5.2 Gram-Negative Bacilli & Opportunistic Pathogens 5.3 Anaerobic Pathogens & Diabetic Foot Infections 5.4 Bacterial Structure, Virulence Factors & Sterilization 5.5 Mycobacteria, Spirochetes, Mycoplasma & Zoonotic Infections 5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines
6 Chapter 6: Mycology, Virology, Parasitology & Clinical Immunology
6.1 Mycology: Dermatophytes, Onychomycosis & Systemic Mycoses 6.2 Clinically Relevant Viruses & Parasitic Infections 6.3 Innate & Adaptive Immunity Mechanisms 6.4 Hypersensitivity Reactions, Immunodeficiencies & Autoimmunity 6.5 Transplant & Tumor Immunology and Immunodiagnostic Methods
7 Chapter 7: General & Cellular Pathology
7.1 Cellular Injury, Adaptations & Cell Death Mechanisms 7.2 Acute vs Chronic Inflammation & Tissue Repair 7.3 Hemodynamic Disorders, Thrombosis, Embolism & Shock 7.4 Neoplasia, Oncogenes, Tumor Suppressors & Cutaneous Tumors
8 Chapter 8: Systemic & Podiatric Pathology
8.1 Atherosclerosis, Peripheral Artery Disease & Diabetic Microangiopathy 8.2 Osteoarthritis, Inflammatory Arthritides & Bone Infections 8.3 Neuropathic Disorders, Charcot Neuroarthropathy & Dermatopathology 8.4 Laboratory Diagnostics, Synovial Fluid & Biopsy Interpretation
9 Chapter 9: Organ-System Pathology
9.1 Anemias, Hemoglobinopathies, Leukemias & Immune Disorders 9.2 Cardiac & Pulmonary Pathology 9.3 Renal, Urogenital & Reproductive Pathology 9.4 Gastrointestinal, Hepatobiliary & Endocrine Pathology
10 Chapter 10: General Pharmacology, Autonomic Drugs & Toxicology
10.1 Pharmacokinetics, ADME & Receptor Dynamics 10.2 Cholinergic Agonists & Muscarinic/Nicotinic Antagonists 10.3 Adrenergic Agonists, Sympatholytics & Clinical Applications 10.4 Cardiovascular Pharmacology in Podiatric Patients 10.5 Drug Interactions, Adverse Effects, Pharmacogenomics & Toxicology
11 Chapter 11: Antimicrobial & Podiatric Therapeutics
11.1 Antibacterial Classes, Mechanisms & Resistances 11.2 Antifungal, Antiviral & Antiparasitic Therapeutics 11.3 NSAIDs, Opioids, Corticosteroids & Anti-Gout Agents 11.4 Local & General Anesthetic Pharmacology
12 Chapter 12: Systemic Pharmacology
12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants 12.2 Insulin & Noninsulin Glycemic Agents 12.3 Respiratory & Gastrointestinal Agents 12.4 DMARDs, Biologics, Antineoplastics & Immunosuppressants 12.5 Hormone Therapy, Bisphosphonates, Antihistamines, Growth Factors & Complementary Agents
13 Chapter 13: General Anatomy: Systemic Gross Anatomy & Neuroanatomy
13.1 Cranial Nerves, Head & Neck Anatomy 13.2 Thoracic Wall, Tracheobronchial Tree, Lungs & Mediastinum 13.3 Abdominal Wall, GI Viscera, Pelvis & Retroperitoneum 13.4 Vertebral Column, Spinal Cord & Upper Extremity Overview 13.5 Neuroanatomy: CNS Organization, Somatosensory & Motor Pathways
14 Chapter 14: Histology, Integument, Embryology & Genetics
14.1 Microscopic Anatomy: Epithelia, Connective Tissue, Muscle & Nerve 14.2 Integumentary System: Dermis, Appendages, Nail Unit & Cutaneous Receptors 14.3 Embryogenesis, Limb Morphogenesis & Postnatal Development 14.4 Medical Genetics & Structural Alterations in Aging
15 Chapter 15: Cellular, Neuromuscular & Cardiovascular Physiology
15.1 Membrane Potential, Ion Channels & Transport Mechanisms 15.2 Action Potentials, Synaptic Transmission & Muscle Contraction 15.3 Cardiac Electrophysiology, ECG & Hemodynamics 15.4 Blood Pressure Regulation, Poiseuille Law & Capillary Dynamics
16 Chapter 16: Organ-System Physiology: Respiratory, Renal, Endocrine, GI & Blood
16.1 Pulmonary Mechanics, Gas Exchange & Acid-Base Regulation 16.2 Renal Filtration, Tubular Transport & Fluid/Acid-Base Balance 16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone 16.4 Gastrointestinal & Hepatobiliary Physiology 16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation 16.6 Exercise Physiology, Thermoregulation & Bone Mechanobiology
17 Chapter 17: Biochemistry: Proteins, Enzymes, Carbohydrates & Signaling
17.1 Amino Acid Chemistry, Protein Structure & Enzyme Kinetics 17.2 Glycolysis, Gluconeogenesis, Glycogen Metabolism & TCA Cycle 17.3 Electron Transport Chain, ATP Synthesis & Metabolic Inborn Errors 17.4 Hormones, Receptors, Second Messengers & Signal Transduction
18 Chapter 18: Biochemistry: Lipids, Molecular Genetics, Blood Chemistry & Nutrition
18.1 Fatty Acid Oxidation, Ketogenesis, Cholesterol & Lipoproteins 18.2 Nucleotide Metabolism, DNA Replication, Transcription, Translation & Repair 18.3 Vitamins, Micronutrients & Inborn Errors of Metabolism 18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins 18.5 Nutrition: Energy Balance, Glycemic Index, Fed-Fast Cycle & Free Radicals
5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections
Key Takeaways Explain This Topic AI
The catalase test reliably differentiates Staphylococci (catalase-positive) from Streptococci and Enterococci (catalase-negative), while the coagulase test differentiates Staphylococcus aureus from coagulase-negative staphylococci such as S. epidermidis and S. saprophyticus.
Methicillin resistance in S. aureus (MRSA) is mediated by the chromosomal mecA gene encoding PBP2a, an altered transpeptidase that confers broad resistance across all standard beta-lactams including penicillins, cephalosporins, and carbapenems.
Staphylococcus epidermidis synthesizes an abundant extracellular polysaccharide glycocalyx (slime layer biofilm), establishing it as the premier cause of indolent, subacute infections on orthopedic hardware, joint prostheses, and internal fixation devices.
Streptococcus pyogenes (Group A Strep) is beta-hemolytic, bacitracin-sensitive, and PYR-positive; its surface M protein provides antiphagocytic defense and molecular mimicry, while post-streptococcal glomerulonephritis can follow either pharyngeal or cutaneous infections.
Corynebacterium minutissimum is a pleomorphic Gram-positive rod causing erythrasma, an interdigital toe web maceration that emits a diagnostic coral-red fluorescence under Wood's lamp (365 nm) due to bacterial coproporphyrin III production.
Last updated: October 2026
5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections
Independent Study Guide Notice: Independent study guide by ExamFinch. This educational resource is developed independently by ExamFinch and is not sponsored, endorsed, or affiliated with the National Board of Podiatric Medical Examiners (NBPME) or Meazure Learning.
Overview & Diagnostic Classification of Gram-Positive Pathogens
Gram-positive bacteria possess a thick, multilayered peptidoglycan cell wall (20–80 nm) that retains the crystal violet-iodine complex during acetone-alcohol decolorization, appearing deep purple under light microscopy. In podiatric practice, Gram-positive cocci—principally Staphylococcus and Streptococcus —represent the overwhelming majority of acute skin, soft tissue, and osteoarticular infections.
The initial laboratory diagnostic branch point for all Gram-positive cocci is the catalase test , which assesses the presence of the enzyme catalase that degrades hydrogen peroxide into water and molecular oxygen ( 2 H 2 O 2 → 2 H 2 O + O 2 2H_2O_2 \rightarrow 2H_2O + O_2 2 H 2 O 2 → 2 H 2 O + O 2 ):
Gram-Positive Cocci ⟶ { Catalase (+): Staphylococcus species (clusters) Catalase (-): Streptococcus & Enterococcus species (pairs/chains) \text{Gram-Positive Cocci} \longrightarrow \begin{cases} \textbf{Catalase (+):} & \text{Staphylococcus species (clusters)} \\ \textbf{Catalase (-):} & \text{Streptococcus \& Enterococcus species (pairs/chains)} \end{cases} Gram-Positive Cocci ⟶ { Catalase (+): Catalase (-): Staphylococcus species (clusters) Streptococcus & Enterococcus species (pairs/chains)
Organism Catalase Coagulase Hemolysis Distinguishing Diagnostic Tests Primary Podiatric Clinical Conditions
Staphylococcus aureus Positive Positive Beta (complete) Ferments mannitol (yellow on MSA); Protein A (+) #1 Acute osteomyelitis, surgical site infections, paronychia, abscesses
Staphylococcus epidermidis Positive Negative Gamma (none) Novobiocin sensitive; biofilm slime producer Orthopedic hardware & implant infections, prosthetic joint sepsis
Staphylococcus saprophyticus Positive Negative Gamma (none) Novobiocin resistant; urease positive Uncomplicated community-acquired UTIs in young females
Streptococcus pyogenes (GAS) Negative Negative Beta (wide) Bacitracin sensitive (Taxo A); PYR positive Erysipelas, rapidly spreading cellulitis, Type II necrotizing fasciitis
Streptococcus agalactiae (GBS) Negative Negative Beta (narrow) Bacitracin resistant; CAMP test (+); Hippurate (+) Diabetic foot ulcer infections, neonatal sepsis, osteomyelitis
Enterococcus faecalis / faecium Negative Negative Gamma / Alpha Grows in 40% bile & hydrolyzes esculin; grows in 6.5% NaCl; PYR (+) Polymicrobial diabetic foot ulcers, chronic osteomyelitis, VRE
Genus Staphylococcus: Pathophysiology & Podiatric Manifestations
Staphylococci appear microscopically as Gram-positive spherical cells arranged in irregular, grape-like clusters (due to cell division occurring across multiple perpendicular planes).
Staphylococcus aureus: Master Pathogen of Bone and Soft Tissue
Staphylococcus aureus is the leading cause of pyogenic skin infections, acute contiguous and hematogenous osteomyelitis, septic arthritis, and post-operative surgical site infections (SSIs) in lower extremity surgery.
Structural & Cell Wall Virulence Factors
Protein A: Surface protein covalently anchored to the peptidoglycan wall that binds the Fc region of IgG antibodies in an inverted orientation. By binding the constant Fc domain rather than the antigen-binding Fab domain, Protein A inhibits classic complement fixation via C1q, eliminates Fc-receptor recognition by polymorphonuclear neutrophils (PMNs), and blocks opsonophagocytic clearance.
Fibronectin-Binding Proteins (FnBPA, FnBPB) & Clumping Factor (ClfA): Mediate high-affinity adherence to host extracellular matrix components, exposed collagen, and blood clots on surgical implants and damaged bone trabeculae.
Polysaccharide Microcapsule (Types 5 and 8): Shields against phagocytosis in deep tissue compartments.
Enzymatic Virulence Factors
Coagulase: Existing as both bound coagulase (clumping factor, detected via slide agglutination) and free coagulase (extracellular staphylocoagulase, detected via tube test reacting with plasma coagulase-reacting factor / CRF). Converts host fibrinogen into insoluble fibrin meshworks , encasing the bacteria in a protective mechanical shield that blocks leukocyte migration.
Catalase: Decomposes host neutrophil-derived hydrogen peroxide within the phagolysosome, facilitating intracellular survival.
Hyaluronidase ("Spreading Factor"): Hydrolyzes hyaluronic acid within the ground substance of human connective tissue, permitting bacterial infiltration through subcutaneous tissue spaces.
Staphylokinase (Fibrinolysin): Digests fibrin clots, allowing secondary dissemination from localized abscesses.
Lipases: Degrade host cutaneous lipids and sebum, facilitating colonization of hair follicles, paronychial folds, and sebaceous tissue.
Exotoxins & Superantigens
Toxic Shock Syndrome Toxin-1 (TSST-1): A potent superantigen that bypasses intracellular antigen processing. TSST-1 directly cross-links the external surface of the Class II Major Histocompatibility Complex (MHC II) molecule on antigen-presenting cells to the V-beta domain of the T-cell receptor (TCR) . This non-specifically activates up to 20% of circulating CD4+ helper T cells, precipitating a catastrophic cytokine storm characterized by massive secretion of Interleukin-1 (IL-1), Interleukin-2 (IL-2), Tumor Necrosis Factor-alpha (TNF-alpha), and Interferon-gamma (IFN-gamma). Patients present with high fever, profound refractory hypotension, multi-organ dysfunction, and a diffuse macular erythroderma resembling sunburn that later desquamates on the palms and soles.
Exfoliative Toxins (ETA and ETB): Serine proteases that selectively cleave desmoglein-1 , a core cadherin trans-membrane cell-cell adhesion molecule situated exclusively within the stratum granulosum of the epidermis. Cleavage produces intraepidermal blistering, manifesting as bullous impetigo or widespread Staphylococcal Scalded Skin Syndrome (SSSS / Ritter disease) in infants and neonates. SSSS displays a positive Nikolsky sign (gentle lateral skin stroking induces epidermal detachment), spares mucosal surfaces, and yields sterile blisters (as the pathology is toxin-mediated from a remote focus).
Enterotoxins (A through E): Heat-stable, acid-resistant superantigens that induce intense vomiting and watery diarrhea within 2 to 6 hours of consuming preformed toxin in food (staphylococcal food poisoning).
Panton-Valentine Leukocidin (PVL): A bicomponent, pore-forming cytotoxin frequently carried on the mobile genetic element of Community-Acquired MRSA (CA-MRSA). PVL rapidly lyses human neutrophils and macrophages, inducing extensive tissue necrosis, severe furunculosis, and aggressive necrotizing soft tissue infections.
- Important
- Mechanisms of Staphylococcal Resistance: MSSA vs. MRSA
Penicillinase-Mediated Resistance (MSSA): Staphylococci initially developed resistance to natural penicillins through plasmid-encoded β \beta β -lactamase ( blaZ ), which hydrolyzes the cyclic amide bond of the β \beta β -lactam ring. Methicillin-Sensitive S. aureus (MSSA) remains fully susceptible to penicillinase-resistant semisynthetic penicillins (oxacillin, nafcillin, dicloxacillin) and β \beta β -lactam/ β \beta β -lactamase inhibitor combinations (ampicillin-sulbactam, amoxicillin-clavulanate).
Altered Target Site Resistance (MRSA): Methicillin-Resistant S. aureus is defined by the acquisition of the chromosomal mecA gene , carried on the mobile Staphylococcal Cassette Chromosome mec (SCC mec ). The mecA gene encodes an altered, low-affinity transpeptidase designated Penicillin-Binding Protein 2a (PBP2a) . PBP2a continues catalyzed peptidoglycan transpeptidation even in the presence of saturating concentrations of virtually all traditional β \beta β -lactam antimicrobials. Consequently, MRSA strains are clinically resistant to all penicillins, all cephalosporins (generations 1 through 4), and all carbapenems . The exceptions are the anti-MRSA cephalosporins ceftaroline and ceftobiprole (FDA-approved in 2024), which bind PBP2a.
Coagulase-Negative Staphylococci (CoNS)
Coagulase-negative Staphylococci lack free coagulase and were historically dismissed as harmless cutaneous commensals. However, they represent significant opportunistic pathogens in podiatric and orthopedic surgery.
Staphylococcus epidermidis
Microbiology: Catalase-positive, coagulase-negative, novobiocin sensitive (zone of inhibition ≥ 16 mm \ge 16\text{ mm} ≥ 16 mm on disk diffusion).
Pathogenesis: The hallmark virulence attribute of S. epidermidis is its capacity to produce an extracellular polysaccharide glycocalyx / biofilm (slime layer) . Upon initial contact with synthetic biomaterials, S. epidermidis utilizes surface autolysins and microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) to adhere to host plasma proteins (fibronectin, fibrinogen) coating the implant. The bacteria subsequently synthesize polysaccharide intercellular adhesin (PIA), forming complex multilayered sessile communities embedded in a protective hydrated slime matrix.
Clinical Relevance: S. epidermidis is the primary pathogen implicated in subacute, indolent orthopedic implant infections , prosthetic total ankle arthroplasty loosening, osteosynthetic plate/screw colonization, and central venous catheter sepsis. Biofilms protect embedded bacteria from host phagocytosis and reduce antimicrobial penetration by up to 1,000-fold, often necessitating surgical hardware removal for definitive cure.
Staphylococcus saprophyticus
Microbiology: Catalase-positive, coagulase-negative, novobiocin resistant (zone of inhibition < 16 mm < 16\text{ mm} < 16 mm ).
Clinical Relevance: Second only to E. coli as a cause of acute, uncomplicated community-acquired urinary tract infections in sexually active young women; rare in isolated foot infections.
Genus Streptococcus: Hemolysis, Grouping & Clinical Syndromes
Streptococci are fastidious, catalase-negative, facultatively anaerobic Gram-positive cocci arranged characteristically in pairs or chains. They are categorized based on their hemolytic patterns on 5% sheep blood agar and their cell-wall carbohydrate antigens (Lancefield grouping):
Alpha-Hemolysis: Incomplete, partial hemolysis producing a greenish discoloration surrounding colonies due to the oxidation of hemoglobin to methemoglobin ( Streptococcus pneumoniae , Viridans streptococci).
Beta-Hemolysis: Complete, clear zone of total erythrocyte lysis ( Streptococcus pyogenes , Streptococcus agalactiae ).
Gamma-Hemolysis: Complete absence of hemolysis ( Enterococcus faecalis , Enterococcus faecium , Streptococcus bovis group).
Streptococcus pyogenes (Group A Streptococcus / GAS)
Streptococcus pyogenes is an aggressive, strictly human pathogen responsible for rapidly propagating cutaneous infections and life-threatening toxin-mediated syndromes.
Laboratory Identification
Beta-hemolytic on sheep blood agar (displays a wide, clear zone of complete lysis).
Bacitracin Sensitive ("Taxo A disc sensitive"): Growth is inhibited by low concentrations ( 0.04 units 0.04\text{ units} 0.04 units ) of bacitracin (distinguishing GAS from the bacitracin-resistant S. agalactiae ).
PYR Positive: Rapidly hydrolyzes L-pyrrolidonyl- β \beta β -naphthylamide (PYR) via pyrrolidonyl arylamidase, producing a bright red color upon reagent addition.
Major Virulence Factors
M Protein: The chief virulence determinant of GAS. Extending hair-like from the peptidoglycan wall, M protein is highly antiphagocytic. It binds host Factor H , destabilizing the alternative complement pathway C3-convertase and halting C3b deposition on the bacterial surface. Furthermore, hypervariable amino-terminal regions of M protein exhibit molecular mimicry with human cardiac myosin, tropomyosin, and synovial antigens, serving as the immunologic driver of Acute Rheumatic Fever .
Hyaluronic Acid Capsule: Chemically indistinguishable from human ground substance hyaluronic acid, rendering the organism entirely non-immunogenic and invisible to host phagocytes.
Streptolysin O (SLO) & Streptolysin S (SLS): SLO is an oxygen-labile, cholesterol-binding pore-forming hemolysin that is immunogenic; neutralizing host antibodies form the basis of the anti-streptolysin O (ASO) titer . SLS is oxygen-stable, non-immunogenic, and responsible for the clear beta-hemolysis observed on aerobic blood agar.
Streptokinase: Catalyzes the conversion of host plasminogen into active plasmin , which enzymatically digests fibrin barriers and blood clots, accelerating rapid bacterial tissue spread.
Hyaluronidase: Cleaves host hyaluronic acid ground substance ("spreading factor").
Streptococcal Pyrogenic Exotoxins (SpeA, SpeB, SpeC): SpeA and SpeC are superantigens responsible for scarlet fever (strawberry tongue, sandpaper exanthem) and Streptococcal Toxic Shock-Like Syndrome (STSS) . SpeB is a potent extracellular cysteine protease that rapidly cleaves human extracellular matrix, immunoglobulins, and complement, driving severe tissue destruction in necrotizing fasciitis.
Podiatric & Cutaneous Manifestations
Erysipelas: An acute, fiery red, superficial cutaneous infection involving the upper dermis and superficial dermal lymphatics . Classically presents on the lower extremity with sharply demarcated, distinctly elevated borders , rapid onset of heat, marked induration, and systemic fever.
Cellulitis: Diffuse, acute infection extending deeper into the deep dermis and subcutaneous adipose tissue . In contrast to erysipelas, cellulitis displays flat, poorly demarcated borders without sharp margins.
Type II Necrotizing Fasciitis ("Streptococcal Gangrene"): A surgical emergency characterized by monomicrobial invasion of deep fascial planes along anatomical compartments. Hallmarks include excruciating pain out of proportion to physical exam findings, rapid progression from erythema to dusky violaceous bullae, cutaneous anesthesia (due to thrombosis of cutaneous microvessels and sensory nerve necrosis), and rapid hemodynamic collapse. Emergent radical surgical debridement and dual antimicrobial therapy with Penicillin G (bactericidal cell wall action) plus Clindamycin (ribosomal 50S inhibition to suppress SpeA/SpeB toxin synthesis and counteract the "Eagle effect" in high-inoculum stationary phase) are mandatory.
- Note
- Post-Streptococcal Non-Suppurative Sequelae
Acute Rheumatic Fever (ARF): Develops 2 to 4 weeks following untreated streptococcal pharyngitis ONLY . It does NOT occur following primary cutaneous streptococcal infections (impetigo or cellulitis). Characterized by the Jones criteria (Carditis, Polyarthritis, Sydenham chorea, Erythema marginatum, Subcutaneous nodules).
Post-Streptococcal Glomerulonephritis (PSGN): A Type III immune complex-mediated nephritic disease that develops 1 to 6 weeks following streptococcal pharyngitis OR primary cutaneous infections (impetigo, pyoderma, cellulitis) . Immune complexes deposit within the subepithelial space ("lumpy-bumpy" humps on electron microscopy), causing hematuria ("cola-colored urine"), hypertension, oliguria, and periorbital edema.
Streptococcus agalactiae (Group B Streptococcus / GBS)
Streptococcus agalactiae possesses the Group B Lancefield carbohydrate antigen and is a major pathogen in patients with diabetes mellitus and peripheral vascular disease.
Diagnostic Identification
Beta-hemolytic with a narrow, subtle zone of clear hemolysis.
Bacitracin Resistant: Uninhibited by Taxo A discs.
CAMP Test Positive: When streaked perpendicularly to a central streak of β \beta β -lysin-producing Staphylococcus aureus on sheep blood agar, GBS secretes the CAMP factor (a diffusible extracellular protein), which interacts synergistically with staphylococcal β \beta β -lysin to produce an arrowhead-shaped zone of complete hemolysis .
Hippurate Hydrolysis Positive: Hydrolyzes sodium hippurate to sodium benzoate and glycine, detected by ninhydrin reagent turning deep purple.
Podiatric Significance
While renowned as the primary cause of neonatal meningitis and sepsis acquired during vaginal delivery, in adult podiatric medicine GBS is a frequent isolate in diabetic foot ulcers , chronic heel decubitus ulcers, cellulitis, and secondary osteomyelitis, often acting synergistically in polymicrobial soft tissue infections.
Genus Enterococcus: Characteristics & Resistance Profiles
Enterococci—predominantly Enterococcus faecalis (85–90% of clinical isolates) and Enterococcus faecium (10–15%)—were formerly classified as Group D Streptococci. They represent resilient commensal organisms of the normal mammalian gastrointestinal tract.
Laboratory Identification
Microscopic morphology: Gram-positive cocci occurring in pairs and short chains.
Hemolysis: Typically non-hemolytic (gamma), though alpha-hemolytic strains occur.
Bile Esculin Hydrolysis: Capable of growing in the presence of 40% bile salts and hydrolyzing esculin into esculetin. Esculetin reacts with ferric citrate in the medium to form a characteristic dark brown / black precipitate .
Growth in 6.5% NaCl Broth: Tolerates hypertonic saline environments (differentiating Enterococci from non-enterococcal Group D streptococci like Streptococcus gallolyticus / bovis ).
PYR Positive: Confirms pyrrolidonyl arylamidase activity.
Clinical Podiatric Importance & Resistance Paradigms
Enterococci possess substantial intrinsic resistance mechanisms that complicate empiric antimicrobial therapy in chronic lower extremity wounds and osteomyelitis:
Intrinsic β \beta β -Lactam Resistance: Low-affinity Penicillin-Binding Proteins (PBPs), particularly PBP5 in E. faecium , render Enterococci intrinsically resistant to all cephalosporins across all generations and reduce susceptibility to penicillins.
Intrinsic Aminoglycoside Resistance: Low-level resistance due to poor drug penetration across the cell envelope; synergy requires co-administration of a cell-wall active agent (ampicillin or vancomycin) to facilitate aminoglycoside uptake.
Vancomycin-Resistant Enterococci (VRE): Highly prevalent in hospitalized patients, particularly with E. faecium . Mediated by acquired operons (chiefly vanA and vanB ) that enzymatically remodel peptidoglycan precursor pentapeptides. The normal terminal sequence D-alanyl-D-alanine (to which vancomycin binds with high affinity through five hydrogen bonds) is altered to D-alanyl-D-lactate (or D-alanyl-D-serine). This single atom substitution removes a hydrogen bond, resulting in a 1,000-fold reduction in vancomycin binding affinity .
Treatment of VRE: Requires advanced non- β \beta β -lactam agents such as linezolid (oxazolidinone inhibiting 50S ribosomal subunit initiation complex), daptomycin (lipopeptide inserting into calcium-dependent membrane channels), or tigecycline .
Gram-Positive Bacilli of Podiatric & Systemic Importance
Although Gram-positive cocci dominate foot pathology, several rod-shaped Gram-positive bacilli present with hallmark dermatologic and systemic features tested on national licensing examinations. Gram-Positive Bacilli
- │
- ┌────────────────────────────┴───────────────────────────┐
- Spore-Forming Non-Spore-Forming
- │ │
- ┌────────┴────────┐ ┌─────────┴─────────┐
- Aerobic Anaerobic Motile Non-Motile
- (Bacillus) (Clostridium) (Listeria) (Corynebacterium)
- │ │ │ │
- B. anthracis C. perfringens L. monocytogenes C. minutissimum
- B. cereus C. tetani (Tumbling motility (Erythrasma: coral-red
- C. botulinum at 25°C; cold Wood's lamp; porphyrin)
- C. difficile enrichment)
- Corynebacterium minutissimum & Erythrasma
Corynebacterium minutissimum is a slender, pleomorphic, non-spore-forming, catalase-positive Gram-positive bacillus that inhabits the stratum corneum as normal human cutaneous flora.
Pathophysiology & Clinical Presentation
Under conditions of excessive local moisture, heat, hyperhidrosis, obesity, or diabetes mellitus, C. minutissimum proliferates within the superficial cornified epithelium, causing erythrasma :
Topography: Most commonly localizes to intertriginous and macerated interdigital spaces of the foot—predominantly the 4th interdigital web space (between the 4th and 5th toes)—as well as the inguinal folds and axillae.
Lesion Morphology: Presents as well-demarcated, reddish-brown to copper-colored macules or patches with fine cigarette-paper-like wrinkling, subtle epidermal scaling, and chronic maceration.
Diagnostic Pearl: Wood's Lamp Examination
When illuminated under a long-wave ultraviolet Wood's lamp (365 nm) , erythrasma displays an unmistakable, brilliant coral-red fluorescence . This optical phenomenon is generated by the bacterial synthesis and accumulation of coproporphyrin III within the infected stratum corneum.
Differential Diagnosis: Erythrasma is routinely misdiagnosed as tinea pedis or interdigital candidiasis. Unlike fungal infections, potassium hydroxide (KOH) wet mounts of erythrasma scrapings reveal no hyphae or pseudohyphae. Furthermore, tinea pedis does not fluoresce coral-red under Wood's lamp.
Therapy: Directed topical therapy with erythromycin or clindamycin solution, or oral macrolides (erythromycin or clarithromycin) for extensive involvement.
Genus Bacillus: Spore-Forming Aerobes
Bacillus anthracis: Large, non-motile Gram-positive spore-former. Possesses a unique poly-D-glutamic acid capsule (the only bacterial capsule composed of polypeptides rather than polysaccharides), which resists phagocytosis. Synthesizes a tripartite exotoxin: Protective Antigen (PA) (binds host cells and translocates toxin), Edema Factor (EF) (calmodulin-dependent adenylate cyclase that elevates intracellular cAMP, causing massive tissue edema), and Lethal Factor (LF) (zinc-dependent metalloprotease that cleaves MAP kinase kinase, triggering macrophage lysis and tissue necrosis). Cutaneous anthrax inoculation produces an initial painless pruritic papule that rapidly evolves into a vesicle and ruptures to form a characteristic painless black necrotic eschar surrounded by extensive gelatinous edema.
Bacillus cereus: Motile, non-encapsulated spore-former that causes food poisoning: the emetic syndrome (rapid onset within 1–5 hours following ingestion of preformed cereulide toxin in reheated fried rice) and the diarrheal syndrome (onset within 8–16 hours from heat-labile enterotoxin stimulating intestinal adenylate cyclase).
Listeria monocytogenes: Intracellular Cold-Tolerant Pathogen
Listeria monocytogenes is a small, facultatively intracellular Gram-positive bacillus displaying unique physical properties:
Tumbling Motility: Demonstrates characteristic end-over-end "tumbling motility" at room temperature (20–25°C) mediated by peritrichous flagella, but is non-motile at 37°C due to transcriptional repression of flagellin genes.
Cold Growth ("Psychrophile"): Capable of multiplying at temperatures as low as 4°C, permitting proliferation in refrigerated ready-to-eat deli meats, unpasteurized soft cheeses, and hot dogs.
Intracellular Pathogenicity: Phagocytosed into host cells, it utilizes listeriolysin O (LLO) (a pore-forming cytolysin) and phospholipases to rupture the phagolysosomal membrane and escape into the neutral host cytosol. It then expresses the bacterial surface protein ActA , which hijacks host actin filaments to form "actin rockets" (actin comets) , propelling the bacterium directly across the plasma membrane into adjacent host cells without entering the extracellular space.